Latest Stemgent Stories
LONDON, July 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Xcelthera Inc and its joint research partner San Diego Regenerative Medicine Institute are granted U.S. Patent No.
- Stemgent to provide CellDesign's proprietary adipocyte differentiation kits - SAN DIEGO and NEW HAVEN, Conn., March 24 /PRNewswire/ -- Stemgent has signed a co-exclusive license to market CellDesign's AdipoDesign Starter Kit and AdipoDesign MaxiKit, which enable researchers to grow and study adipocytes from adipogenic progenitor cells.
- totally perplexed and mixed up.